Effect of an Education Programme for Patients With Osteoarthritis in Primary Care - a Randomized Controlled Trial

March 30, 2015 updated by: Eva Ekvall Hansson, Lund University
Osteoarthritis is a common disease. The core treatment is often patient education. The aim of this study is therefore to study the effect of a patient education programme for patients with osteoarthritis in primary health care.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Osteoarthritis (OA) is a degenerative disease, considered to be one of the major national diseases that cause suffering for affected patients and costs for society.The predominant symptoms are pain, stiffness and impaired quality of life, often together with psychological distress. Treatment often consists of medication. Later in the disease, when the joint is destroyed, joint replacement surgery commonly occurs. Physical exercises aimed to increase muscle strength, endurance, proprioception and stability have proved to influence cartilage as well as function, symptoms and quality of life positively. Physical exercise may also reduce the need for hospital care after knee joint replacement.

Research suggests that patient education is feasible and valuable in terms of improvements in quality of life, in function, in well-being and improved coping . Accordingly, guidelines recommend education as a core treatment for osteoarthritis.

Patient education programmes are often defined as a planned learning experience to influence a patient's knowledge and health behaviour [13]. There are various types of patient education. It can be given by a physician as part of consultation, in small groups or delivered by a multi-disciplinary team [13, 14] Since 1994, Primary Health Care in Malmö has used a patient education programme directed towards OA. The programme has been developed by physiotherapists and occupational therapists in primary health care and has been implemented in the ordinary work.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
    • Skåne
      • Malmö, Skåne, Sweden, 205 02
        • Primary Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of osteoarthritis

Exclusion Criteria:

  • Must be able to speak and understand swedish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient education programme
Patients with osteoarthritis who were referred to the patient education programme.The patients followed the patient education programme.
Other: Patient education programme
The intervention consisted of five group sessions, three hours for each session. The focus was on self-efficacy. Eight to ten patients participated in the programme at the same time.
No Intervention: Control
Patients randomized to control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
EQ5D
Time Frame: At baseline and at follow-up after 6 months
At baseline and at follow-up after 6 months
Arthritis self-efficacy scale
Time Frame: At baseline and at follow up after 6 months
At baseline and at follow up after 6 months
One-leg rising from sitting to standing
Time Frame: At baseline and at follow up after 6 months
At baseline and at follow up after 6 months
Grip Ability Test
Time Frame: At baseline and at follow up after 6 months
At baseline and at follow up after 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Bipedal rising from sitting to standing
Time Frame: At baseline and at follow up after 6 months
At baseline and at follow up after 6 months
One-legged jump
Time Frame: At baseline and at follow up after 6 months
At baseline and at follow up after 6 months
Standing on one leg with eyes open and standing on one leg with eyes closed
Time Frame: At baseline and at follow up after 6 months
At baseline and at follow up after 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lund University

Collaborators

Region Skåne, Primary health care, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Primary Completion (Actual)

March 1, 2009

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

September 17, 2009

First Submitted That Met QC Criteria

September 17, 2009

First Posted (Estimate)

September 18, 2009

Study Record Updates

Last Update Posted (Estimate)

March 31, 2015

Last Update Submitted That Met QC Criteria

March 30, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PEPOA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe